ArticleCancer discovery2015
Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors.
Garrett M Frampton et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
437 papers cite itlatest 60 shown
this paperpooled ittrialcites it